- Home
- ASTL vs SANA Comparison
ASTL vs SANA Comparison
Compare ASTL & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTL
- SANA
- Stock Information
- Founded
- ASTL 1902
- SANA 2018
- Country
- ASTL Canada
- SANA United States
- Employees
- ASTL N/A
- SANA N/A
- Industry
- ASTL Steel/Iron Ore
- SANA Medicinal Chemicals and Botanical Products
- Sector
- ASTL Industrials
- SANA Health Care
- Exchange
- ASTL Nasdaq
- SANA Nasdaq
- Market Cap
- ASTL 477.1M
- SANA 519.8M
- IPO Year
- ASTL N/A
- SANA 2021
- Fundamental
- Price
- ASTL $5.13
- SANA $1.77
- Analyst Decision
- ASTL
- SANA Strong Buy
- Analyst Count
- ASTL 0
- SANA 5
- Target Price
- ASTL N/A
- SANA $9.50
- AVG Volume (30 Days)
- ASTL 1.1M
- SANA 3.9M
- Earning Date
- ASTL 06-20-2025
- SANA 05-07-2025
- Dividend Yield
- ASTL 3.92%
- SANA N/A
- EPS Growth
- ASTL N/A
- SANA N/A
- EPS
- ASTL N/A
- SANA N/A
- Revenue
- ASTL $1,706,096,151.00
- SANA N/A
- Revenue This Year
- ASTL $9.58
- SANA N/A
- Revenue Next Year
- ASTL $13.20
- SANA N/A
- P/E Ratio
- ASTL N/A
- SANA N/A
- Revenue Growth
- ASTL N/A
- SANA N/A
- 52 Week Low
- ASTL $4.17
- SANA $1.26
- 52 Week High
- ASTL $12.14
- SANA $10.50
- Technical
- Relative Strength Index (RSI)
- ASTL 46.35
- SANA 47.51
- Support Level
- ASTL $4.65
- SANA $1.53
- Resistance Level
- ASTL $4.89
- SANA $1.91
- Average True Range (ATR)
- ASTL 0.38
- SANA 0.20
- MACD
- ASTL 0.13
- SANA 0.06
- Stochastic Oscillator
- ASTL 69.06
- SANA 75.00
About ASTL Algoma Steel Group Inc.
Algoma Steel Group Inc is a fully integrated steel producer of hot and cold rolled steel products, including coiled sheet and plate, strategically located. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.